Merck to seek emergency use for COVID-19 antiviral pill that cuts severe outcomes by 50 percent
By
Alicia Lasek
Oct 04, 2021
Molnupiravir has reduced COVID-19 deaths and hospitalizations by half in a new clinical trial. An orally delivered drug could offer unprecedented treatment convenience, the drug’s developers say.
Boosters on the way: LTC residents, healthcare workers may top fed’s list after CDC approves 3rd shot
By
Alicia Lasek
Aug 16, 2021
The Biden administration has secured 100 million COVID-19 vaccine doses as part of a strategy to provide additional shots to already vaccinated priority groups this fall, investigators have been told....
FDA may grant Pfizer vaccine full approval by Labor Day: report
By
Alicia Lasek
Aug 05, 2021
The nationwide rise in COVID-19 cases driven by the highly transmissible delta strain has spurred the agency move quickly, sources told The New York Times.
FDA accelerates timetable for full approval of Pfizer vaccine
By
Danielle Brown
Aug 05, 2021
It may soon be “go” time for providers that have thus far held off on mandating COVID-19 vaccines for staff members, basing their decisions on the fact vaccines have been approved by the Food and...
Vaccinated long-term care residents in the clear from COVID-19 — for now
By
Danielle Brown
Jul 12, 2021
Long-term care residents and staff fully vaccinated against COVID-19 don’t need booster shots anytime soon, according to federal health officials.
While FDA moves to halt mask reuse, N95 access remains spotty, report finds
By
Alicia Lasek
Apr 15, 2021
A new push to ensure that healthcare facilities stockpile single-use or reusable N95 respirators has arrived while some workers continue to lack access to the equipment and U.S. mask manufacturers can’t...
FDA approves first fully at-home COVID-19 test
By
Alicia Lasek
Dec 17, 2020
Results are available in about 20 minutes via a mobile phone app, and the test is more than 90% accurate in both symptomatic and asymptomatic individuals, the agency announced Tuesday.
Clinical briefs for Friday, Oct. 23
By
Alicia Lasek
Oct 23, 2020
Remdesivir becomes first fully FDA-approved COVID-19 treatment in U.S. … Soy consumption may decrease key risk factor for dementia … COVID mortality rate widening between U.S. and peer countries …...
Promising antidepressant fails in late-stage trial
By
Alicia Lasek
Dec 05, 2019
Fast-tracked antidepressant Sage-217 failed to outperform a placebo in a stage 3 trial, according to its developer.
Clinical Briefs for Wednesday, Nov. 6
By
Alicia Lasek
Nov 05, 2019
Single odds-defying case may lead to new Alzheimer’s treatments … Fully digital Alzheimer’s study to track risk factors in 400,000 volunteers … Blood samples may identify those at risk for frailty...